NP47823b Multiple Sclerosis Additions

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Supply)
Duration
15 month (est.)
Value
£34M
Sector
HEALTH
Published
02 Feb 2024
Delivery
06 Feb 2024 to 30 Apr 2025 (est.)
Deadline
n/a

Concepts

Location

Edinburgh

Geochart for 2 buyers and 4 suppliers

2 buyers

4 suppliers

Description

Supply of multiple sclerosis medicines to NHS Scotland.

Lot Division

1 Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules

Supply of teriflunomide tablets, dimethyl fumarate gastro resistant capsules, and fingolimod capsules to NHS Scotland. The Authority awarded the Framework Agreement as a single supplier framework agreement per product line to three (3) Framework Participants.
2 Natalizumab Solution for Infusion Vials and Injection Pre-filled Syringes

Supply of natalizumab solution for infusion vials and injection pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a supplier framework agreement per product line to one (1) Framework Participant.

Award Detail

1 Biogen Idec (Maidenhead)
  • Natalizumab Solution for Infusion Vials and Injection Pre-filled Syringes
  • Num offers: 1
  • Value: £17,322,900
2 Ranbaxy (London)
  • Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules
  • Num offers: 15
  • Value: £17,035,260 [share]
  • Awarded to group of suppliers.
3 Viatris UK Healthcare (Hatfield)
  • Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules
  • Num offers: 15
  • Value: £17,035,260 [share]
  • Awarded to group of suppliers.
4 Wockhardt (Wrexham)
  • Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules
  • Num offers: 15
  • Value: £17,035,260 [share]
  • Awarded to group of suppliers.

Award Criteria

Technical (Supply Chain) / Weighting 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the fourteen (14) month Framework Agreement duration and the thirty-four (34) month extension period of the Framework Agreement. Details of individual lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:755577)

Reference

Domains